Name | N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine |
---|---|
Synonyms |
4-Quinazolinamine, N-1H-indazol-5-yl-2-(6-methyl-2-pyridinyl)-
N-(1H-Indazol-5-yl)-2-(6-methyl-2-pyridinyl)-4-quinazolinamine N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine |
Description | CID 9998128 is a potential multi-target drug for the Alzheimer's disease (AD), inhibits the Aβ42 amyloid fibrillization and is capable to clear Aβ42 fibrils; strongly binds to both amyloid beta 42 (Aβ42) fibrils and β-secretase and the van der Waals interaction is dominating over the electrostatic interaction in binding affinity. |
---|---|
References | References 1. Thai NQ, et al. ACS Chem Neurosci. 2018 May 18. doi: 10.1021/acschemneuro.8b00091. View Related Products by Target Amyloids |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 536.9±50.0 °C at 760 mmHg |
Molecular Formula | C21H16N6 |
Molecular Weight | 352.392 |
Flash Point | 278.5±30.1 °C |
Exact Mass | 352.143646 |
LogP | 3.06 |
Vapour Pressure | 0.0±1.4 mmHg at 25°C |
Index of Refraction | 1.779 |